Education
About Us
Working with TipRanks
Follow Us
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 812.03M | $ 412.26M | $ 306.13M | $ 258.49M | $ 294.01M |
| Gross Profit | $ 539.17M | $ 178.78M | $ 89.31M | $ 80.02M | $ 184.16M |
| Operating Income | $ 45.11M | $ -257.12M | $ -319.55M | $ -315.76M | $ 139.09M |
| EBITDA | $ 11.38M | $ -182.95M | $ -260.80M | $ -245.89M | $ 254.46M |
| Net Income | $ -537.96M | $ -281.89M | $ -341.42M | $ -320.83M | $ 27.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 800.09M | $ 66.15M | $ 121.59M | $ 409.62M | $ 132.54M |
| Total Assets | $ 1.13B | $ 343.73M | $ 412.90M | $ 717.42M | $ 2.61B |
| Total Debt | $ 378.99M | $ 424.26M | $ 217.27M | $ 270.87M | $ 1.75B |
| Net Debt | $ -418.81M | $ 360.31M | $ 160.87M | $ 163.68M | $ 1.69B |
| Total Liabilities | $ 548.36M | $ 2.84B | $ 2.56B | $ 2.42B | $ 1.91B |
| Stockholders' Equity | $ 577.31M | $ -2.50B | $ -2.14B | $ -1.70B | $ 702.24M |
| Cash Flow | |||||
| Free Cash Flow | $ 66.89M | $ -253.64M | $ -298.42M | $ -327.96M | $ 57.57M |
| Operating Cash Flow | $ 83.16M | $ -245.20M | $ -276.10M | $ -285.71M | $ 277.02M |
| Investing Cash Flow | $ -16.26M | $ 52.93M | $ 214.77M | $ -282.99M | $ -33.97M |
| Financing Cash Flow | $ 664.99M | $ 200.29M | $ 10.13M | $ 10.45M | $ -249.88M |